Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathology. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnoses and treatment programs. Treatment and management of the EJ syndrome requires multidimensional management, including personalized development, usually drug therapy, rehabilitation interventions, and regular follow-up.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune diseases that were previously difficult to treat have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored during the treatment process, and timely adjusted according to the changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of EJ syndrome.
The platform serves a team of internationally authoritative experts in the field of self-immunity and rheumatic immunity within the China International Medical Service System, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.